LSTA

Lisata Therapeutics, Inc. LSTA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LSTA MTVA NCNA ENLV PASG XCUR CASI CLSD PTHS KLTO
6M -18.65 % 31.73 % -81.13 % -38.65 % 67.02 % 4.35 % -41.08 % -92.06 % 124.58 % -70.89 %
YTD -42.58 % -57.60 % -98.65 % -37.66 % -34.40 % -60.47 % -74.30 % -93.02 % 124.58 % -47.98 %
1Y -34.50 % -50.58 % -98.74 % -38.16 % -17.50 % -65.22 % -75.05 % -92.83 % 124.58 % -21.06 %
3Y -18.74 % -64.64 % -99.91 % -79.76 % -55.73 % -3.23 % -48.24 % -93.99 % 124.58 % -64.67 %
5Y -90.51 % -64.64 % -99.99 % -92.25 % -98.02 % -97.84 % -97.38 % -96.86 % 124.58 % -64.67 %
10Y -98.76 % -64.64 % -100.00 % -99.53 % -97.55 % -98.71 % -92.10 % -99.08 % 124.58 % -64.67 %
From the beginning -100.00 % -64.64 % -100.00 % -99.77 % -97.55 % -98.71 % -99.96 % -99.08 % 124.58 % -64.67 %

Dividend

Lisata Therapeutics, Inc.